Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); ASH Preview: High Expectations Going Into Data Presentations
Tweet Send to a Friend
Canaccord Genuity maintains a 'Sell' rating on Seattle Genetics (NASDAQ: SGEN), PT $10.
Canaccord analyst says, "In our view, expectations ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "In our view, expectations ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
